Our deficiency explainer established who is likely to be low and why testing beats guessing. This companion answers the operational questions: what exactly to request at the laboratory, why the same blood can produce different numbers at different labs, and how to translate your printed result into an actual decision. Consider it the user manual for the single most informative test in nutritional medicine.
What to ask for, by name
The correct request is “serum 25-hydroxyvitamin D, total” — often printed as 25(OH)D, calcidiol, or vitamin D 25-OH. “Total” matters: it captures both 25(OH)D3 (from skin synthesis and D3 supplements) and 25(OH)D2 (from fungal sources and D2 preparations), which together define status. Two tests to not confuse it with: 1,25-dihydroxyvitamin D — the active hormone, tightly regulated, useful only in specific kidney and calcium disorders, and famously capable of reading “normal” in true deficiency; and direct “vitamin D” (cholecalciferol) assays, which measure the short-lived parent compound rather than the storage form. If a requisition form offers choices, 25(OH)D total is the status test; everything else answers different clinical questions.
Why laboratories disagree: methods and standardisation
Send one sample to three laboratories and you may receive three numbers several ng/mL apart — a known property of the field, not sloppiness at any one bench. Two method families dominate: immunoassays (antibody-based, automated, what most routine labs run) and LC-MS/MS (mass spectrometry — the reference-quality method that counts the molecules directly and separates D2 from D3). Immunoassays vary in how completely they detect 25(OH)D2 and certain metabolites, producing systematic offsets between platforms. The field’s answer is the international Vitamin D Standardization Program (VDSP), anchored to NIST reference materials, which participating laboratories use to calibrate their assays to a common truth. Two practical consequences: for one-off assessment, any VDSP-aligned or reputable accredited laboratory is adequate; for tracking over time — always retest at the same laboratory, so method offset cancels out and the change you see is biology, not chemistry.
Reading the printed result
Three reading skills cover almost every report. Units first: results come as ng/mL or nmol/L, differing by a factor of 2.5 (20 ng/mL = 50 nmol/L) — the single most common cause of misread reports and internet confusion. Reference range ≠ clinical thresholds: the range printed beside your result is often a population or assay-derived interval, not a clinical judgment; interpretation belongs to the threshold frameworks — deficiency below 20 ng/mL (50 nmol/L) by all major bodies; the 20–30 ng/mL band sufficient per IOM/EFSA-aligned frameworks but “insufficient” per the Endocrine Society’s clinical guideline; 30+ ng/mL satisfying every framework; and no evidence of added benefit at high-normal levels, with toxicity territory beginning far above (100+ ng/mL, essentially always supplement-induced). Timing context: 25(OH)D has a 2–3-week half-life integrating months of exposure — a late-winter test catches your annual nadir (the most informative single measurement at latitudes like Georgia’s), a late-summer test your peak; and after any dose change, retesting is meaningful at 8–12 weeks, when the new steady state has formed, not at two.
From number to decision
The decision logic, compressed: below 20 ng/mL — supplementation is warranted by any framework, with dose proportionate to the deficit and body weight, and clinician involvement for severe deficiency or complicating conditions; 20–30 — a judgment zone where risk factors, symptoms and goals (with your clinician) tip the scale; above 30 — maintenance at most, and above ~60 with supplements, a reasonable prompt to reduce. Every correction decision closes the loop with the 8–12-week retest at the same laboratory — the step that converts supplementation from standing guess to titrated intervention, and the entire practical point of the fat-taken, D3-form, drop-titratable supplementation stack the rest of our series describes.
The clinical bottom line
Order “25-hydroxyvitamin D, total”; know your units (×2.5 between systems); trust trends only within one laboratory; read the number against clinical thresholds (deficiency
Primary sources
- Holick MF, et al. Endocrine Society clinical practice guideline: evaluation, treatment, and prevention of vitamin D deficiency. J Clin Endocrinol Metab. 2011;96(7):1911-30
- Sempos CT, Binkley N. 25-Hydroxyvitamin D assay standardisation and vitamin D guidelines paralysis. Public Health Nutr. 2020;23(7):1153-1164 — via the CDC Vitamin D Standardization-Certification Program
- CDC: Vitamin D Standardization-Certification Program (VDSP)
- EFSA: Dietary reference values for vitamin D
- GMJ: Vitamin D deficiency — who is at risk
Was this article helpful?
Disclaimer. This article is health journalism intended for general information and education. It is not medical advice and is not a substitute for professional diagnosis or treatment. Always consult a qualified healthcare provider about your individual circumstances. Full disclaimer →
Related Coverage
Editorial standards. This article was produced under the GMJ News editorial process, with oversight by the GMJ Editorial Board. Our editorial process. Spotted an error? Contact the editorial team.
